Neoadjuvant Chemoimmunotherapy versus Neoadjuvant Chemoradiotherapy versus Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Real-World, Three-Arm, Retrospective Cohort Study from the Chinese National Cancer Center.

Technol Cancer Res Treat · 2026 · PMC13247292 · PMID 42259509

Europe PMC DOI

hedged sentence

0.1960

closest p · 3.9× alpha

0.1960

boldest claim

The sentences

did not reach statistical significancep = 0.196not close (p > 0.1)

As for RFS, there is a similar trend but did not reach statistical significance (HR = 0.729, 95% CI = 0.542-1.177, p = 0.196).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.